ReviewPlant biotechnology journal2026
Synthetic Biology and Metabolic Engineering of Microalgae for Sustainable Lipid and Terpenoid Production: An Updated Perspective.
Review in Plant biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Microalgal cell factories for bioenergy and climate action: a circular bioeconomy roadmap.Microbial cell factories · 2026Review
- Triacylglycerol synthesis in microalgae under abiotic stress: an updated integrative review.Plant & cell physiology · 2026Review
- Next-generation biodiesel production: catalytic innovations and scalable microalgal biorefinery systems.RSC advances · 2026Review
- The Mevalonate Pathway: Innovations, Applications, and Challenges in Biotechnology with Emphasis on Fungal Biology.Journal of fungi (Basel, Switzerland) · 2026Review
- Screening of the TwoMicroorganisms · 2026Article
- Article
- Synthetic Biology and Metabolic Engineering of Microalgae for Sustainable Lipid and Terpenoid Production: An Updated Perspective.Plant biotechnology journal · 2026Review
- Harnessing microalgae for bioproducts: innovations in synthetic biology.World journal of microbiology & biotechnology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Microalgae are increasingly recognised as powerful platforms for the sustainable production of lipids and terpenoids, with expanding applications in the food, fuel and biomanufacturing industries. In this updated review, we consolidate and critically assess the most recent advances in synthetic biology and metabolic engineering of key microalgal models, including Chlamydomonas reinhardtii, Nannochloropsis spp. and Phaeodactylum tricornutum. We focus on developments that have emerged in the latest waves of research, emphasising novel genetic toolkits that accelerate the Design-Build-Test-Learn (DBTL) cycle, breakthroughs in genome-scale metabolic modelling, and innovative strategies for organelle-targeted biosynthesis of high-value compounds. Recent case studies are compared to highlight trends in successful engineering approaches. By capturing these up-to-date insights, this review outlines the current trajectory of microalgal biotechnology toward scalable, carbon-neutral biofactories for polyunsaturated fatty acids (PUFAs) and diverse terpenoids, reinforcing their role in global sustainability and the circular bioeconomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.